Status:
COMPLETED
Comparative Study of Phototherapy for Hyperbilirubinemia
Lead Sponsor:
GE Healthcare
Conditions:
Hyperbilirubinemia
Eligibility:
All Genders
1-1 years
Phase:
NA
Brief Summary
Hyperbilirubinemia is a common problem for term and preterm newborns in intensive care nurseries around the world. It is a condition in which there is too much bilirubin in the blood. Bilirubin is a s...
Eligibility Criteria
Inclusion
- \> 23 0/7 weeks gestation
- \> 500 grams
- Non-hemolytic or presumed physiologic jaundice (within the first 14 days of life)
Exclusion
- Known congenital infection (proven bacterial or viral etiology)
- Known hemolytic diseases such as but not limited to ABO or Rh incompatibility, minor blood group incompatibility, glucose-6-phosphate dehydrogenase deficiency, or hereditary red blood cell membrane defects (Coombs or DAT positive)
- Suspected genetic, syndromic, or hepatic disorder-
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2008
Estimated Enrollment :
82 Patients enrolled
Trial Details
Trial ID
NCT00635375
Start Date
March 1 2008
End Date
August 1 2008
Last Update
January 13 2009
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Christiana Hospital
Newark, Delaware, United States, 19718
2
University of Tennessee
Knoxville, Tennessee, United States, 37920